| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $673.0M | +20.1% |
| R&D Expense | $750.0M | +7.5% |
| SG&A Expense | $349.0M | +8.5% |
| Operating Income | -$535.0M | +0.2% |
| Pre-tax Income | -$571.0M | -0.6% |
| Income Tax | $4.0M | +150.5% |
| Net Income | -$575.0M | -1.0% |
| EPS (Basic) | -$5.83 | +7.3% |
| EPS (Diluted) | -$5.83 |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $421.0M | +142.3% |
| Accounts Receivable | $158.0M | +29.7% |
| Inventory | $52.0M | +15.5% |
| Current Assets | $951.0M | +16.4% |
| Total Assets | $1.53B | +1.9% |
| Current Liabilities | $384.0M | +11.6% |
| Total Liabilities | $1.60B | +29.3% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$466.0M | -12.5% |
| Capital Expenditures | $6.0M | -19.9% |
| Investing Cash Flow | $236.0M | +1428.2% |
| Financing Cash Flow | $478.0M | +19.7% |
| Free Cash Flow | -$472.0M | -11.9% |
| +7.3% |
| Stockholders' Equity |
| -$80.0M |
| -131.3% |